John H. Dodd - Concepedia

Author

John H. Dodd

Also Known As

Dodd, J.H., Dodd, John H., J H Dodd, J. DODD, J. H. DODD, J. H. Dodd, John Dodd, John H Dodd, John H. Dodd, Marina Raikhel

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Bristol-Myers Squibb (Japan)Johnson & Johnson (United States)Bristol-Myers Squibb (Sweden)

About

John H. Dodd is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	31	1.4K
2	Biochemistry	19	23	897
3	Natural Sciences	18	22	824
4	Engineering	3	3	54
5	Allergy	1	1	111

John H. Dodd

Publications

Citations

H-Index

Page 1

	Year	Citations
Imidazopyrimidines, potent inhibitors of p38 MAP kinase Kenneth C. Rupert, James R. Henry, John H. Dodd, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryP38 Map KinaseMedicinePharmacological AgentPharmacotherapy	2003	249
Selective Itk Inhibitors Block T-Cell Activation and Murine Lung Inflammation Tai-An Lin, Kim W. McIntyre, Jagabandhu Das, Biochemistry Inflammatory Lung DiseaseLung InflammationT-regulatory CellImmunologyImmunologic Mechanism	2004	111
Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes. Robert F. Bruns, James H. Fergus, Linda L. Coughenour, Molecular Pharmacology	1990	105
Phosphodiesterase 7A-Deficient Mice Have Functional T Cells Guchen Yang, Kim W. McIntyre, Robert M. Townsend, The Journal of Immunology	2003	97
Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-<i>f</i>][1,2,4]triazine p38α Mitogen-Activated Protein Kinase Inhibitors John Hynes, Alaric J. Dyckman, Shuqun Lin, Journal of Medicinal Chemistry	2007	81
6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (RWJ 68354): A Potent and Selective p38 Kinase Inhibitor James R. Henry, Kenneth C. Rupert, John H. Dodd, Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapyChemical BiologyPharmaceutical ChemistryPre-clinical Pharmacology	1998	77
Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors Jagabandhu Das, Joseph A. Furch, Chunjian Liu, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetBiochemistryMedicineNatural Sciences	2006	74
5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP Kinase Chunjian Liu, Stephen T. Wrobleski, James C. Lin, Journal of Medicinal Chemistry 5-Cyanopyrimidine DerivativesDrug TargetP38 InhibitorsCellular PharmacologyPharmacotherapy	2005	70
Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-<i>N</i>-propylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases Chunjian Liu, James C. Lin, Stephen T. Wrobleski, Journal of Medicinal Chemistry P38α Enzymatic AssayPharmacotherapyInflammatory ArthritisInflammationMolecular Pharmacology	2010	57
Synthesis of tetrahydroindeno[1,2-b]indol-10-ones and their rearrangement to [2]benzopyrano[4,3-b]indol-5-ones James L. Bullington, John H. Dodd The Journal of Organic Chemistry Derivative (Chemistry)Molecular SciencesDonut IconAltmetric Attention ScoreOrganic Chemistry	1993	56

Page 1